Treatment of moderate to severe asthma: patient perspectives on combination inhaler therapy and implications for adherence.

PubWeight™: 0.89‹?›

🔗 View Article (PMC 3048599)

Published in J Asthma Allergy on July 30, 2009

Authors

Kevin R Murphy1, Bruce G Bender

Author Affiliations

1: Allergy, Asthma and Pulmonary Research, Boys Town National Research Hospital, Omaha, Nebraska, USA;

Articles cited by this

Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med (2004) 8.39

Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax (1992) 5.37

Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med (2004) 4.37

Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. Lancet (2006) 3.93

Compliance with national asthma management guidelines and specialty care: a health maintenance organization experience. Arch Intern Med (1998) 2.52

Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast. J Allergy Clin Immunol (2000) 2.51

Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol (2004) 2.44

Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial. Drugs (2006) 2.26

No symptoms, no asthma: the acute episodic disease belief is associated with poor self-management among inner-city adults with persistent asthma. Chest (2006) 2.26

Compliance, adherence, and concordance: implications for asthma treatment. Chest (2006) 2.21

Reasons for pediatrician nonadherence to asthma guidelines. Arch Pediatr Adolesc Med (2001) 2.03

Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies. J Allergy Clin Immunol (2004) 1.99

The burden of asthma in the United States: level and distribution are dependent on interpretation of the national asthma education and prevention program guidelines. Am J Respir Crit Care Med (2002) 1.92

Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids. Eur Respir J (2002) 1.79

Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option? Eur Respir J (2005) 1.70

Guidelines for the diagnosis and management of asthma. National Heart, Lung, and Blood Institute. National Asthma Education Program. Expert Panel Report. J Allergy Clin Immunol (1991) 1.66

EXCEL: A randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma. Respir Med (2006) 1.65

Patient-identified barriers to asthma treatment adherence: responses to interviews, focus groups, and questionnaires. Immunol Allergy Clin North Am (2005) 1.65

Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations. Int J Clin Pract (2007) 1.64

Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma. Curr Med Res Opin (2004) 1.57

Real-world Evaluation of Asthma Control and Treatment (REACT): findings from a national Web-based survey. J Allergy Clin Immunol (2007) 1.49

Budesonide and formoterol in a single inhaler improves asthma control compared with increasing the dose of corticosteroid in adults with mild-to-moderate asthma. Chest (2003) 1.42

Medication non-adherence and asthma treatment cost. Curr Opin Allergy Clin Immunol (2004) 1.34

Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma. Curr Med Res Opin (2004) 1.21

Adherence rate to inhaled corticosteroids and their impact on asthma control. Allergy (2009) 1.21

Adherence to asthma controller medication regimens. Respir Med (2005) 1.21

Barriers to adherence to asthma management guidelines among inner-city primary care providers. Ann Allergy Asthma Immunol (2008) 1.21

Stability of asthma control with regular treatment: an analysis of the Gaining Optimal Asthma controL (GOAL) study. Allergy (2008) 1.20

Overcoming barriers to nonadherence in asthma treatment. J Allergy Clin Immunol (2002) 1.19

Budesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstriction. Pulm Pharmacol Ther (2004) 1.19

Persistence, adherence, and effectiveness of combination therapy among adult patients with asthma. J Allergy Clin Immunol (2006) 1.17

Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol (2000) 1.14

Asthma treatment preference study: a conjoint analysis of preferred drug treatments. Chest (2004) 1.14

Onset of bronchodilation of budesonide/formoterol vs. salmeterol/fluticasone in single inhalers. Pulm Pharmacol Ther (2001) 1.10

Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma. Respir Med (1999) 1.08

Quality and access to care among a cohort of inner-city adults with asthma: who gets guideline concordant care? Chest (2005) 1.04

The patient's perspective: adherence or non-adherence to asthma controller therapy? J Asthma (2006) 1.03

A new treatment satisfaction measure for asthmatics: a validation study. Qual Life Res (2000) 0.97

Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children. Cochrane Database Syst Rev (2008) 0.94

Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma. Clin Ther (2007) 0.94

Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients. J Allergy Clin Immunol (2008) 0.92

Salmeterol/Fluticasone combination inhaler: a new, effective and well tolerated treatment for asthma. Clin Drug Investig (1998) 0.90

Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers. Can Respir J (1999) 0.89

Interpreting clinical trial results of patient-perceived onset of effect in asthma: methods and results of a Delphi panel. Curr Med Res Opin (2009) 0.89

Factors influencing patient decisions about the use of asthma controller medication. Ann Allergy Asthma Immunol (2007) 0.89

Onset of effect of budesonide and formoterol administered via one pressurized metered-dose inhaler in patients with asthma previously treated with inhaled corticosteroids. Ann Allergy Asthma Immunol (2008) 0.88

Adherence to treatment: assessment of an unmet need in asthma. J Investig Allergol Clin Immunol (2006) 0.86

Insight into patient dissatisfaction with asthma treatment. Arch Intern Med (2001) 0.84

Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids. J Asthma (2008) 0.82

Inhaled Glucocorticosteroid and Long-Acting beta(2)-Adrenoceptor Agonist Single-Inhaler Combination for Both Maintenance and Rescue Therapy : A Paradigm Shift in Asthma Management. Treat Respir Med (2006) 0.81

Comparison of the bronchodilating effects of inhaled formoterol, salmeterol and salbutamol in asthmatic patients. Pulm Pharmacol Ther (2002) 0.81

Patient-reported outcomes in adults with moderate to severe asthma after use of budesonide and formoterol administered via 1 pressurized metered-dose inhaler. Ann Allergy Asthma Immunol (2008) 0.81

The effect of budesonide and formoterol in one pressurized metered-dose inhaler on patient-reported outcomes in adults with mild-to-moderate persistent asthma. Curr Med Res Opin (2008) 0.80

Development and validation of an onset of effect questionnaire for patients with asthma. Allergy Asthma Proc (2008) 0.77

Budesonide/Formoterol pressurized metered-dose inhaler. Drugs (2008) 0.77

Comparison of the bronchodilating effects of formoterol and albuterol delivered by hydrofluoroalkane pressurized metered-dose inhaler. Treat Respir Med (2005) 0.76

Articles by these authors

Family influences on pediatric asthma. J Pediatr Psychol (2004) 1.72

Fifty-one prenatally diagnosed children and adolescents with sex chromosome abnormalities. Am J Med Genet (2002) 1.44

Genetic counseling for sex chromosome abnormalities. Am J Med Genet (2002) 1.37

Effects of X-monosomy and X-linked imprinting on superior temporal gyrus morphology in Turner syndrome. Biol Psychiatry (2003) 1.27

Factors influencing parent reports on quality of life for children with asthma. J Asthma (2003) 1.17

Prevalence and correlates of household exposures to tobacco smoke and pets in children with asthma. J Pediatr (2002) 1.08

Reduced size of the amygdala in individuals with 47,XXY and 47,XXX karyotypes. Am J Med Genet (2002) 1.01

Use of RE-AIM to develop a multi-media facilitation tool for the patient-centered medical home. Implement Sci (2011) 1.01

Adherence to inhaled corticosteroids: an ancillary study of the Childhood Asthma Management Program clinical trial. J Allergy Clin Immunol (2011) 1.01

Relations among asthma knowledge, treatment adherence, and outcome. J Allergy Clin Immunol (2003) 0.99

Adverse consequences of glucocorticoid medication: psychological, cognitive, and behavioral effects. Am J Psychiatry (2014) 0.95

An official ATS workshop report: issues in screening for asthma in children. Proc Am Thorac Soc (2007) 0.88

Relating children's attentional capabilities to intelligence, memory, and academic achievement: a test of construct specificity in children with asthma. Child Neuropsychol (2007) 0.88

Measuring adherence with the Doser CT in children with asthma. J Asthma (2004) 0.85

Predicting asthma control using patient attitudes toward medical care: the REACT score. Ann Allergy Asthma Immunol (2009) 0.82

Sleep disorders in patients with asthma, atopic dermatitis, and allergic rhinitis. J Allergy Clin Immunol (2005) 0.79

Adolescent decision-making about use of inhaled asthma controller medication: results from focus groups with participants from a prior longitudinal study. J Asthma (2011) 0.78

Predicting moderate improvement and decline in pediatric asthma quality of life over 24 months. Qual Life Res (2010) 0.77

In the eye of the patient. J Allergy Clin Immunol (2003) 0.77

Nonadherence to COPD treatment: what have we learned and what do we do next? COPD (2012) 0.76

Effect of pimecrolimus cream 1% on skin condition and sleep disturbance in children with atopic dermatitis. J Allergy Clin Immunol (2004) 0.76

Suicidal ideation and thought disorder associated with the formoterol component of combined asthma medication. Pediatr Pulmonol (2012) 0.75

Retrospective and prospective parental reports of sleep in children with asthma. J Allergy Clin Immunol (2004) 0.75

An Official American Thoracic Society Research Statement: Implementation Science in Pulmonary, Critical Care, and Sleep Medicine. Am J Respir Crit Care Med (2016) 0.75